NCT00492128View on ClinicalTrials.gov

Kanagawa Combination Anti-hypertensive Therapy (K-CAT)

PHASE4CompletedINTERVENTIONAL
Enrollment

196

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

May 31, 2009

Study Completion Date

August 31, 2010

Conditions
Hypertension
Interventions
DRUG

Losartan/amlodipine or losartan/hydrochlorothiazide

Losartan 50mg/amlodipine 5mg and the fixed dose combination drug of losartan 50mg/hydrochlorothiazide 12.5mg once a day during 12 months.

Trial Locations (1)

236-0004

Yokohama City University Graduate School of Medicine, Yokohama

All Listed Sponsors
lead

Yokohama City University Medical Center

OTHER

NCT00492128 - Kanagawa Combination Anti-hypertensive Therapy (K-CAT) | Biotech Hunter | Biotech Hunter